ARCHIVES

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

This article is from The Cancer Letter archive.

Vol. 38 No. 45 | December 7, 2012

Download PDF Visit The Full Archive

Related Articles

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources

October 24, 1980

Doctors Are Doing More Cancer Screening, ACS Survey Finds

March 30, 1990

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013